Taipei Medical University Institutional Repository:Item 987654321/44547
217
0
0
全文
(2) II.
(3) III.
(4) IV.
(5) V.
(6) (Patent Guider 2008) tea. green. (1976 (1976. ~2010. 12. ) ~2010. 12. ). 12. ) (1976. (1976. ~2010. ) (1976. ~2010. 12. ~2010. ). 11371. IPC (International Patent Classification) 2236 359 PatentTech /. :. I. 12.
(7) Abstract Our study was to explore the perspective of green tea by the patent trend analysis such as finding the key technologies, understanding the distribution and application of green tea technology, investing resource and competitors operated the tactics, developing the trends of the green tea technology in the future, reducing the time for research and development (R & D) and saving its costs and avoiding waste of human resources. We speculate this patent analysis mode can create and develop a high value of green tea products in commercial market. All green tea patents were analyzed by Patent Guider 2008 Software which was developed by LEARNINGTECH TECH Company at Taoyuan. This program covered from 1976 to Decembert 2010 (total 11371 patents). The total patent number was 359 after judging and screening by literature review, expert interviews and IPC (International Patent Classification) search system. The results showed the life cycle of green tea was in growing period that suggested its market of values have a new awareness and invested in a lot of resources by manufacturers. Our preliminary data illustrate China and Japan owned the most patents in the green tea technology (63.9% in analysis cases). These study focus on herbal applications, especially in the "regulation of blood sugar", "regulation of the immune" and "Obesity", however the derived technologies were used in "solvent extraction", "enzyme extraction", "increased concentration of nutrients" and "added flavor". That is the greatest potential technology in the future.. KEY WORDS : Green Tea, Catechin, Patent Map. II.
(8) 99. 2011/07/28. III.
(9) ............................................................................................................ I ........................................................................................................... II ..................................................................................................................III ..................................................................................................................IV ............................................................................................................... V ............................................................................................................ VII ......................................................................................................1 ...............................................................................................4 ....................................................................................4 ............................................................................9 ..................................................................................17 ..........................................................................21 ..............................................................................................25 .............................................................................................32 .............................................................................................34 ......................................................................34 ......................................................................37 ....................................................................................................40 ...................................................40 ...............................................................43 / ( ) .......................................................51 / ( ) .......................................................62 ....................................................................................................71 ......................................................................72 ...............................................................83 ...............................................................86 ...............................................................92 ...........................................................96 .........................................................................................98 ...........................................................................................100 ..................................................................................................124 酚. IV.
(10) 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚. 酚酚酚1苸苷麦-2醯1醯 酚酚酚 酚酚酚 酚酚酚 酚酚酚 酚酚酚 酚酚酚2醯醯肤 酚酚酚 酚酚酚 酚酚酚杨锋廰 酚 酚 酚 酚 酚 酚 杨锋廰 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚酚酚 酚 酚 酚. 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 3酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 麦酚 螯螯螯螯 11酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷酚 螯螯螯螯 22酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 2麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 3术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 3麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 4醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 41酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 42酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 4麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 4苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 术醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 术3酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 术4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 术苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 术苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 麦3酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 麦4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 麦苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 麦苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 肤4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 肤术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 肤麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 肤肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 肤苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 苷1酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 苷2酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 苷术酚 术 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 苷苸酚. V.
(11) 酚 酚 酚 酚. 酚 酚 酚调临W酚廰护A锋龙临驰酚杨调廰 酚. 螯螯螯螯螯螯螯螯螯螯螯螯螯螯 苸醯酚 螯螯螯螯螯螯螯螯螯螯螯螯 苸1酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 苸4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 苸肤酚 酚. VI.
(12) 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚. 酚酚酚 酚酚酚 酚酚酚2醯醯麦 酚酚酚2醯醯肤 酚酚酚2醯醯肤 酚酚酚 酚酚酚 酚酚酚 酚酚酚 酚酚酚 酚 酚 酚 酚 酚 酚 酚 酚 / 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚酚酚 酚 酚 酚. 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 124酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 12术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 12术酚 螯螯螯螯螯 12麦酚 螯螯螯 12麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 12肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 12肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 12苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 12苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 12苸酚 -酚杨锋廰 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 12苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 13醯酚 -酚杨锋廰 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 13醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 131酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 131酚 杨锋廰 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 132酚 杨锋廰 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 132酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 133酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 134酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 134酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 13术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 13术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 13麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 13麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 13肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 13肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 13苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 13苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 13苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 13苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 14醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 14醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 141酚. VII.
(13) 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚. 酚 酚 酚 酚 酚 酚 酚酚酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚酚酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚酚酚 酚 酚 酚 酚 酚 酚 酚 酚. 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 141酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 142酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 142酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 143酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 143酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 144酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 144酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 14术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 14术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 14麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 14麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 14肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 14肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 14苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 14苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 14苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 14苸酚 / 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术1酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术1酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术2酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术2酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术3酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术3酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术苸酚. VIII.
(14) 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚. 酚 酚酚酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚酚酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚酚酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚. /. 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1术苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦1酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦1酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦2酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦2酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦3酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦3酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦麦酚 / 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1麦苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤1酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤1酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤2酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤2酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤3酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤3酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤肤酚. IX.
(15) 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚. 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚 酚. 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1肤苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷1酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷1酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷2酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷2酚 / 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷3酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苷苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸醯酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸1酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸1酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸2酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸2酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸3酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸3酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸4酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸术酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸术酚. X.
(16) 酚 酚 酚 酚 酚 酚 酚 酚 酚. 酚 酚 酚 酚 酚 酚 酚 酚 酚. /. 孙D锋. 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸麦酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸肤酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸苷酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 1苸苸酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 2醯醯酚 酚 螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯螯 2醯1酚. XI.
(17) (Thea sinensis). (. 2005). (. 1995). EGCG (Epigallocatechin gallate) (Butt and Sultan 2009). DNA. (Meeran. et al 2009). (Low-Density. Lipoproteins LDL) 1997). (Tijburg et al. LDL. (High. Density Lipoprotein Cholesterol HDL-C) al 2002). Body Mass Index (BMI). 1. (Yokozawa et.
(18) (Shimotoyodome et al 2005). ( 40% (. 2003). 60%. 2000) (Ernst 1998). 2010. 1986 61%. 2.
(19) 1986-2010 Table 1. Patent Statistics in 1986-2010. 2010. 3.
(20) :. (. 2007). ). (. 1.. 60 -70% 95. 4.
(21) Table 2. Classification of tea by fermentation. 酚 酚. 2.. Table 3. Classification of tea by withering. 5.
(22) 3. 6 :. Table 4. Classification of tea by color. ( (. 酚 酚. ) ) ( ( (. 酚. ) ). → →. →. → →. → →. ). ( ( ( (. ) ) ) ). (. ) (. ). ( ( (. → →. ) ) ). (. ). (. → →. →. →. →. → →. → →. → → →. → → →. ). (. ). ( (. ) ) (. ) (. ( (. ) ) ). 6.
(23) 2002. >. >. >. (. 2002). ( 2003). 2008. (Syu et al 2008). 7.
(24) (. ). 30% - 40%. ( catechins ). 75-80% gallate (ECG) (EC). epigallocatechin gallate (EGCG) 46.8% epicatechin. 13.54%. gallocatechin gallate (GCG). 8.07% gallocatechin (GC). 2.26%. catechin (C ). 2.46%. 7.24% epicatechin. epigallocatechin (EGC). 2.22% (Sartippour et al 2001) gallate EGCG GCG ECG. EGC. GC EC. C. EGC. GC. EC. C. (Nakagawa and Yokozawa 2002). (Bigelow and Cardelli 2006) (Thangapazham et al 2007) (Butt and Sultan 2009). (Meeran et al 2009) (Butt and Sultan 2009). LDL. (Tijburg et al 1997) (Yokozawa et al 2002). 8.
(25) :. DNA (Devasagayam et al 2004). (Brand et al 2004) LDL (Low-density lipoprotein) (. 1995). ( glutathione reductase GSHRd). (superoxide dismutase SOD). ( catalase CAT). (Heck et al 2005). 9.
(26) C. E. (Crespy and Williamson 2004) 2005 50. 13. 600. (. (. wash-out) 780. ). ( trolox equivalent antioxidant capacity TEAC) ( thiobarbituric acid-reactive substances. TBARS). (reduced glutathione GSH). (glucose-6-phosphate dehydrogenase (glutathione peroxidase. G-6-PDH) GSH Px). reductase GSHRd) (. 2005). LDL (Crespy and Williamson 2004). 10. (catalase) (glutathione.
(27) Table 5. Effects of green tea catechins on cardiovascular disease in animal models. (Crespy and Williamson 2004). 11.
(28) 2003. Raederstorff. g/day/kg BW. 0.25. 0.2 g/day/kg BW. 0.5. 0.4. 1% (0.7 g/day/kg BW). 4. 1% (Raederstorff et al 2003). Miura. (0.8 g/L). 2001 8. (Miura et al 2001) 2009 65. -85. ( ). 1999. 2006. 6. 7. 7 (Suzuki et al 2009). 2009 (. 374 69. ). 2007. 1-2. 2008 (Liang et al. 2009). 12.
(29) (. (Mu et al 2003) (Kumar et al 2007) Mukhtar 2006). 1999). (Suganuma et al 2006). (Zhang et al 2007). (Adhami and. (Yusuf et al 2007) :. (1) (activator protein-1. AP-1). JB6 Epidermal growth factor (EGF) plasminogen activator(tPA). Tissue. AP-1. DNA. (Dong et al 1997) (Shimizu et al. 2005) (2). (Weidner et al 1992) (Toi et al. 13.
(30) 1993). 1995. Sazuka. L22-Lu3. Lewis lung carcinoma. EGCG. (Sazuka et al 1995) HT1080. MMP-9 Cao. 50 µM. Maeda-Yamamoto. 20 µM EGCG ECG. degradation. (Maeda-Yamamoto et al 1999). MMP-2 1999. 20 µM EGCG 1.25%. (VEGF) (3). (Cao et al 1999) (apoptosis). 2000 A31. (. Ahmad. ). (Ahmad et al 2000). (. 2006) 2005. 5. (low-fat LF) 14. (high-fat HF).
(31) (green tea extract and high fat GTE-HF) (exercise and high fat EX-HF) (green tea extract and exercise and high fat GTEEX-HF) 15. GTE-HF. GTEEX-HF. 47% 24%. 58% 37%. EX-HF. 89%. 87% (green tea extract. GTE). (Shimotoyodome et al 2005). (1). A A. 320 400 nm. A. matrix metalloproteinases , MMP. MMP. A A. MMP. (Song et al. 2004). 15.
(32) A. Psoralen with UltraViolet A Light PUVA. (. 2005). (2). B B. 290 320 nm. A. B B. PGE2 leukocyte infiltration MMP B. pyrimidine (Bae et al 2008). 16.
(33) 1999. 2011. 2. 3. 05. 2002. 1. 30. 210 13. 10 ( ). : Streptococcus mutans. 2005. : : :. 2010. : 10. 17.
(34) 50%. 70%. Table 6. Through the "Healthy Food Certification" of green tea. A00022 (. ). A00060 A00061 A00074 A00084. (. ). A00089 A00117 A00160 A00179. 2011. 18.
(35) (. 2005). 2008. 4. 2008 677. (. IMS. 2010). 2009. 759. 2010 900. (. 840 3. 2011 10. 2010). 19.
(36) (. ) (. 20. 2005).
(37) 1990. 2001. 2006 4.5%. 10. 35.7% 2006. ( ). 15-39. 15-19. 30-39. (. 51.0%. 15-39. ). 21.
(38) 2007 Table 7. Analyses of preference ratio for various tea drinks by age in Taiwan consumer in 2007. 1. (N=1200). 2 2007. 70.8% 15-49. 30-39 50-70 15-49. (. 4. ). 2008 22.
(39) 2009. 5. (2009. 26. 20. 2010. 2. 200. 2009. ) 2008. 15%. 30. 2%. 2009 (. 2009). Datamonitor. Co-Q10. ω-3 (. 2010). 23.
(40) 2006 103.3 2008. 1,380. 3,200. 2007. 1,359. 900. 101.2. 1,500. 101.5 (2009. 1,333. 3,900. 101.9 2009. 1,397. ). 2008 98 1,371. 6. 2008. 1. 226. 15% 21%. 14%. AC 40%. 5%. 30%. 25%. 2009. 2009. (2009. 24. ). 8.
(41) 10 51,921. 88 97. 93. 7. 83,613. 55%. 1. 10 97. 28,041. 86.89%. 25.
(42) Table 8. Statistic of approve patents. :. 2007. 26.
(43) (1). (2). (. 27. 2005).
(44) (1). :. (2). (3). :. 28.
(45) (. ). (1). :. (2). :. (3). :. 29.
(46) (Pilkington et al., 2002). (Fabry et al., 2006). :. 30.
(47) (1). (2). (3). (4). 31.
(48) 500. (2005. ) :. WIPO). 90%. 95%. 80% 60%. 40%. 32.
(49) 33.
(50) (Patent Guider 2008) 2010. 1976. 12 green tea. 34.
(51) Table 9. A list of keywords after expert interviews. Green tea and Senescence Green tea and Fatigue Green tea and Immunity or Immune Green tea and Obesity Green tea and Cancer Green tea and Lipid Green tea and Cardiovascular or Heart Green tea and Osteoporosis Green tea and Intestines or Stomach Green tea and Tooth Green tea and Liver Green tea and Iron Green tea and Blood pressure Green tea and Blood sugar Green tea and Skin Green tea and Supercritical Green tea and Nano Green tea and Solvent 35.
(52) (International Patent Classification. IPC). :. IPC Table 10. Setting the conditions for IPC IPC A01N A23D A23F A23L A24B A61F A61H A61K A61L A61Q B01D B01F B01J B02C. A61P. C07 C08 C09B C09K C11B C11D C12C C12G C12N C12P C12Q G01N G03B. 36.
(53) (Patent Guider 2008). IPC. (1) / /. (2). 37.
(54) (3). : 1.. :. 2.. :. 3.. :. 1. 4.. :. (. 38. ).
(55) (4). ….. (5). IPC (International Patent Classification) (International Patent Classification IPC. IPC). IPC. IPC. IPC IPC. ….. Patent Tech 2008 -. 39.
(56) .. (Patent Guider 2008). 1976. 2010. green tea 11371. Table 11. The search of the scope of patent databases. 1976~2010. 1873. 1976~2010. 295. 1976~2010. 1767. 1976~2010. 1359. 1976~2010. 6077. 40. 12.
(57) .. 2236. Table 12. A list of Search plots word (. ). (. ). 41. ( ) Senescence or aging Fatigue Immunity or Immune Obesity Cancer Lipid Cardiovascular or Heart Osteoporosis Intestines or Stomach Tooth Liver Iron Blood pressure Blood sugar Skin Supercritical Nano or technology Solvent.
(58) Table 13. A list of plots word statistics. 59. 32. 314. 287. 1545. A01N A23D A23F A23L A61F A61K A61L A61P A61Q B01D B01F B01J B02C C07 C08 C09B C09K C11B C11D C12C C12G C12N C12P C12Q G01N G03B IPC 32 59 1545. 314. 287. 2236. 42.
(59) (1). /. 1979. 2010 1979. 1980 2010. HORINO KENJI. 12. 1980. 2220. 1984 2003. 259. 337. 1998. 2009. 50. (1980~1998). (1999~2010). 43.
(60) (2) (CN) (RU). (JP). (KR). (US). 784 36.7% 1985. 1986. 11. 1993. 7. 2009. 153 580. 27.2% 1993. 33. 277. 2005. 2007. 39. 13% 63.9%. IPC IPC. IPC. (IPC: A23F003). 784. 561. 580 :. (IPC: A23L001). 345. (IPC: A23F003). (IPC:A61K036) (IPC:A61K008). 290. 276. 249. (IPC: A23L002) (IPC:A61K036). 44. 691. 220.
(61) (3) (. ). : …. Patent Guider 1.2. 1.2. 0.8. 0.8. 0. 0.2. 0.2. 397. 18%. KVASENKOV OLEG IVANOVICH (. 9%). 4. 207. 4. 100%. 2005 2006. 28 109. 5. 207 - IPC (IPC: A23L001). KAO CORP 38%. 7. 52 1986~2010 45. (. 2.3%).
(62) 2-3 (. 54. ). - IPC (IPC: A23F003). Table 14. A list of the top ten companies. KVASENKOV OLEG IVANOVICH KAO CORP AMOREPACIFIC CORP ITO EN LTD TAIYO KAGAKU CO LTD PROCTER & GAMBLE NEW CHAPTER INC NEWMARK THOMAS MITSUI NORIN KK PURDUE RESEARCH FOUNDATION. 207 52 26 21 18 19 21 9 14. 0 0 0 0 0 4 6 23 0. 0 0 0 0 0 0 6 0 0. 11 54 70 32 35 22 8 7 14. 1 1 1 2 1 3 3 1 1. 4 7 3 9 17 7 3 8 19. 4 100% 10 38% 7 30% 10 19% 5 18% 11 16% 7 16% 5 15% 8 11%. 10. 1. 4. 10. 1. 8. 5 9%. 46.
(63) (4). Kvasenkov Oleg Ivanovich Jushina Elena Anatol Evna Ramazanovna,. 228. Kvasenkov Ivan Il'ich,. Tjurjukov Aleksandr Borisovich. Shazzo Fatima. 4. 5. 4 Newmark Thomas 27. Schulick Paul. New Chapter Inc. 1. Kvasenkov Oleg Ivanovich 2006. 112. 47.
(64) Table 15. A list of the top five inventor (. ). JUSHINA ELENA ANATOL EVNA > JUSHINA ELENA KVASENKOV ANATOL'EVNA, > KVASENKOV IVAN IL'ICH, > KVASENKOV OLEG OLEG IVANOVICH > KVASENKOV OLEG IVANOVICH, > IVANOVICH(2005 , SHAZZO FATIMA RAMAZANOVNA, > SHAZZO RAMAZAN 2006 , 2009 , 2010) IZMAILOVICH > SHAZZO RAMAZAN IZMAILOVICH, > TJURJUKOV ALEKSANDR BORISOVICH Board of Regents of the University of Texas System;NEW CHAPTER INC > KATZ AARON;SCHULICK PAUL;NEW CHAPTER INC;NEWMARK THOMAS > NEW CHAPTER INC > NEW CHAPTER INC;Board of Regents of the University of Texas System > NEWMARK NEW CHAPTER INC;CLEVELAND CLINIC FOUNDATION > NEW THOMAS(2001 , CHAPTER INC;THE CLEVELAND CLINIC FOUNDATION > 2002 , 2005 , 2006 , NEWMARK THOMAS > NEWMARK THOMAS;NEW CHAPTER 2007 , 2008 , 2009 , INC;SCHULICK PAUL;KATZ AARON > NEWMARK 2010) THOMAS;SCHULICK PAUL > SCHULICK PAUL;NEW CHAPTER INC;NEWMARK THOMAS;BEMIS DEBRA L;KATZ AARON > SCHULICK PAUL;NEWMARK THOMAS > The Cleveland Clinic Foundation;NEW CHAPTER INC Board of Regents of the University of Texas System;NEW CHAPTER INC > KATZ AARON;SCHULICK PAUL;NEW CHAPTER INC;NEWMARK THOMAS > NEW CHAPTER INC > NEW CHAPTER INC;Board of Regents of the University of Texas System > SCHULICK NEW CHAPTER INC;CLEVELAND CLINIC FOUNDATION > NEW PAUL(2001 , 2002 , CHAPTER INC;THE CLEVELAND CLINIC FOUNDATION > 2005 , 2006 , 2007 , NEWMARK THOMAS > NEWMARK THOMAS;NEW CHAPTER 2008 , 2009 , 2010) INC;SCHULICK PAUL;KATZ AARON > NEWMARK THOMAS;SCHULICK PAUL > SCHULICK PAUL;NEW CHAPTER INC;NEWMARK THOMAS;BEMIS DEBRA L;KATZ AARON > SCHULICK PAUL;NEWMARK THOMAS > The Cleveland Clinic Foundation;NEW CHAPTER INC JUSHINA E.A, > KVASENKOV I.I, > KVASENKOV O I > KVASENKOV O KVASENKOV O.I > KVASENKOV O.I, > LOGVINCHUK T M > I(2005) SHAZZO R.I, > TJURJUKOV A B UEOKA KAO CORP > KAO CORP;ABE TETSUYA;UEOKA HIDEAKI(2006 , HIDEAKI;SHIBATA KEIJI > SHIBATA KEIJI;UEOKA 2007 , 2008 , 2009) HIDEAKI;ABE TETSUYA;KAO CORP. 48. 228. 27. 27. 26. 18.
(65) (5). IPC IPC. IPC IPC. 1320. A61K036. A23L001. A61K036. IPC. 1030 A23L001. IPC. A23F003. A61K008. IPC. IPC. IPC. 4. IPC. A61K036 2000. 2001 2007 175. 49.
(66) IPC. 2000. A61K036. A61K008 IPC. 2003. 128. 62. IPC Table 16. A table of the the main IPC classification. A61K036. 1320 [8]. A23L001. 1030 3/00. A23F003. 887. A61K008. 861. [4]. A45D40/00 [8] A61K031. 502. [2]. 50.
(67) /. ( ). 359. PatentTech / -. / (. ). / /. /. /. / 4(6). 6. 4. 9 6 7. 18. 16 11. 8. 12. 51.
(68) (. ). / /. 19. 84. 10 6. (. ). 34. 13. /. 1981 2009. 10. 1992. 2009. 52. 8.
(69) Table 17. Life cycle analysis based on technology. 21, 22 23, 24 25, 26 27, 28 29, 30. 1981 1992 1992 1992 1992. 1992. 1993. 2009. 2010. 10. 1996. 1997. 2010. 6. 1992. 1993. 2010. 5. 2007. 53.
(70) Table 18. Life cycle analysis based on function. 31, 32 33, 34 35, 36 37, 38 39, 40 41, 42 43, 44 45, 46 47, 48 49, 50. 1993 1997 1996 1993 1998 1990 1993 1993 1992 2007. 54.
(71) /. /. /. / / 5(13) 13 (. 5. ). / /. / /. /. 5 /. 55.
(72) (. ). / /. 85. 8 6 /. (. ). / /. / (CN). 8 (KR). (DE). (JP). (US). (FR). (AU). (CA). 39% 33% 1981 2006. 2001. 2009. 7 2010 56. 9.
(73) 7 (CN). (JP). (DE). (KR). (NL). (IT). (ZA). 38% 15% 1992. 3. (CN). (KR). 76%. (US). 18% 1992. 5. (JP). (US). 2008. (KR). (DE). (CN). (JP). (KR). 26%. 1992 5. (CN) (RU). 40%. 57. (US).
(74) Table 19. Statistics of top countries in technology. 8 3 7 5 5. /. /. 54,55 56,57 58,59 60,61 62,63. 39% 76% 38% 26% 40%. / 6 (CN). 60%. (KR). 15% 1986. (JP) (CN). (US). (DE). (AU). 27%. 20% 1990. (JP) (CN). (CA). (KR). (AU). 58. (KR). (US).
(75) 36.7%. Table 20. Statistics of top countries in function. 3 5 6 4 2 6 5 3 5 2. 77% 31% 60% 71% 50% 27% 52% 60% 27% 50%. /. / /. /. 59. 64,65 66,67 68,69 70,71 72,73 74,75 76,77 78,79 80,81 82,83.
(76) /. /. / / (. ). /. 8(13) 13. (. ). 8 /. / / /. /. 28. 18. 60.
(77) (. ). / /. 85. 22. 72. 26. 20. 24. 15 37. 45. 61. 23 /.
(78) /. ( ). ( ). /. 13 33. (. 10. ). 28. /. 20 7. 59. 22 5. 7 16. 58. ( ). 13. 57. /. 1983 1984. 1990 62.
(79) 5. 2001 2005. 2009 1992. 2007 2009. 1-2 1991. 2007. 2008. Table 21.. Life cycle analysis based on technology. 90, 91 92, 93 94, 95 96, 97 98, 99 100, 101. 1990 1984 2000 1992 1994 1991. 63. 7.
(80) 1992. 2005 2009. 1984. 2005 2009. 14. 18 2010. 1-2. 1999 2007. 12. 2008. Table 22. Life cycle analysis based on function. 102, 103 104, 105 106, 107 108, 109 110, 111 112, 113. 1992 1999 1991 1984 1987 1984. 64.
(81) (. ). / /. 4 (JP) (KR). (. 28 71.4%. 17.9%. ). /. / 4 61 21 62 4. 65.
(82) (. ). /. /. 4 (US). (JP). (CN). (KR). 50% 20% 1990 2007 1-2. (JP). (CN). (US). (KR). 50% 18%. 1984 8. 2007 1994. 15. 2008. 66.
(83) (JP) (IT). (CN). (KR). 57% 33% 1993 2007. 5. 2009. 2008. 2009. (US) (KR). 5. (CN). (JP). 40% 30% 1994 1999. 2001. 2008. 2010. 2. 2. 2000. 1-2. 1991. 2007. 67. 7.
(84) Table 23. Statistics of top countries in technology. 4 4 2 4 4 2. /. 117, 118 119, 120 121, 122 123, 124 125, 126 127, 128. 50% 50% 71% 57% 40% 94%. 4 (JP). (CN). (KR). (US). 53% 12% 1992. (JP) 2005. 2007 2007. (KR). 2009. 9. (CN). (US). 68.
(85) (JP) (US). (CN). (KR). 68%. 19% 1984. (JP). 2005 2009 2007. 9 2009. 7. Table 24. Statistics of top countries in function. 4 2 3 4 3 3. 53% 81% 79% 68% 59% 85% 69. 129, 130 131, 132 133, 134 135, 136 137, 138 139, 140.
(86) (. ). / /. (. ). 26. 33. 17. 28. /. 60. 46. 57 62. 38. 70. 41 /.
(87) 2007. 3. XTC. 2007. 2006 2009. 36. 67% 2007. 1,051. 12.7% (2009. ) 2009. 2010. 759 840. 900. 3. 2010). 10 2006. 4.5%. 2011. 10. 35.7%. 3. 16. 71. (.
(88) :. 1979 1980-099157. 1980 HORINO KENJI. 1980. 7. FROZEN TEA. 1998 1999. (IPC) : .. (A61K036) 72.
(89) 1320. 1982. 2000. 2001 /. : (1) (. (. ). (. ). :. 73. ).
(90) Table 25.. Herbal commonly used immune. T. (2009. 1992 2009 10. 74. ). 1993 2010.
(91) Table 26.. Important patent of immune in herbal. DE4221103A1. 1993/1/7. CN1071844. 1993/5/12. CN1187306A. 1998/7/15. Compsns. Contg. Herbal extracts - of myrrh, mulberry bark, cimicifuga and/or green tea, esp. For oral hygiene. CN101375697A CN101485371A CN101700090A. Health green tea and producing method thereof Composition of radix sophorae 1999/12/29 flavescentis and green tea and its application in treating condyloma A method for preparing dandelion green 2008/4/9 tea 2009/3/4 Safflower green tea low sugar beverage 2009/7/22 Honeysuckle green tea 2010/5/5. CN101715854A. 2010/6/2. CN101731384A. 2010/6/16. CN101837071A. Composition of plant extracts and 2010/09/22 application in preventing or treating scars. CN1239669A CN101156638A. 1999. 12. CN1239669A (Human Papillomavirus HPV). 49 76% (. ). 14% (. 50%). 75. 90%.
(92) Table 27. A comparison table about ointment treat human papillomavirus. (Cheng et al 1999) 2010. 03. CN101658221A. 2010. 9. CN101837071A. CN101658221. (. ). 100. 4 50. 4. 2. 2-3. 2-3 50. 23 24 7. 76.
(93) Table 28. A comparison table of plant extract treat scar. (Baoguo et al 2010). (2). 2010. 10 30. 77.
(94) 1997. 2010. 6. 2002. Nutrition 2007 8. Birketvedt. (Birketvedt et al 2002). 3. WO2007035367A1 US07579027. 78. 2009.
(95) Table 29. Important patent of obesity in herbal. KR20010081369A 2001/8/29. Preparation method of antiobesity green tea. Noodle composition effective in preventing adult disease and reducing body weight, containing KR20040036701A 2004/4/30 wheat flour, rice flour, black rice, black bean, black sesame, red grape, green tea, herba houttuyniae, fructus aurantii immaturus and folium mori Fat foods containing green tea, tangerine peel, calcium from waste KR20040052991A 2004/6/23 shells, chitosan and boiled beans having function of inhibiting lipid absorption and production thereof Composition for treating obesity and constipation containing hot water extracts of pine needle, green tea and black tea as active ingredient, KR20040089258A 2004/10/21 wherein the mixed extracts increases obesity inhibition effect, reduces body weight and body fat, and increase qu Northern white kidney bean extract and red kidney bean extract in WO2007035367A1 2007/3/29 combination with green tea extract in the treatment of obesity Lily green tea beauty treatment CN101366907A 2009/2/18 weight reducing particle Composition for treating obesity comprising extract from white US07579027 2009/8/25 kidney beans, red kidney beans, and green tea leaves Green tea and ginger fat- reducing CN101564067A 2009/10/28 and weight- reducing beverage CN101700090A. 2010/5/5 79.
(96) .. 2007 4,761. 2008. 5,264. 10.57% (2009. ) 2010. IPC (A23L001). 19. (A23F003). 84. 1030. 887. 2009. 01. 1981. : (1) 10. WO2009008569A1 ACAD COOP. 80. UNIV KOREA IND &.
(97) Table 30.. Important patent of immune in food. CN1187306 CN1403017A. 1998/7/15 2003/3/19. CN1586243A. 2005/3/2. Selenium-rich konjaku- green tea health food Green tea bamboo salt spirulina stnff (drink, powder and tablet) and its producing method. WO2009008569A1 2009/1/15. Production methods of green tea extracts for preventing adhesion of pathogenic bacteria to human cell. KR20090027180A 2009/3/16. Manufacturing methods of green tea drink or green tea powder by using the techniques eliminating galated catechin and parathion from green tea extracts. CN101416665A CN101606675A. 2009/4/29 2009/12/23. Preparation method of health- care green tea Method for producing green tea soycheese. CN101658221. 2010/3/3. CN101658221A. 2010/3/3. CN101861898A. 2010/10/20. Green tea beverage for reinforcing immunity, reducing blood fat, losing weight and clearing away summer heat. (2). 2005-2006. -381.
(98) 2007. Cho Am J Physiol Endocrinol Metab. 2007). 2010. (Cho et al. 11. KR20100124519A. Table 31.. Important patent of obesity in food. Powders containing plant extracts e.g. Fucus, green tea, and elder Slimming green tea product and manufacturing method KR20020033452A 2002/5/6 thereof CN1403017A 2003/3/19 Selenium-rich konjaku- green tea health food US06830765 2004/12/14 Green tea extract for treating obesity FR2746648A1. 1997/10/3. TW200538146. 2005/12/1. TW200602343 TW200604190 TW200604189 TW200605799 TW200616559. 2006/1/16 2006/2/1 2006/2/1 2006/2/16 2006/6/1. Manufacturing methods of green tea drink or green tea KR20090027180A 2009/3/16 powder by using the techniques eliminating galated catechin and parathion from green tea extracts CN101658221 2010/3/3 Green tea beverage for reinforcing immunity, reducing CN101658221A 2010/3/3 blood fat, losing weight and clearing away summer heat CN101715854A 2010/6/2 US2010178365A1 2010/7/15 Epicatechin deficient green tea KR20100124519A 2010/11/29 Compositions containing green tea extracts. 82.
(99) :. / ( ). pH 2.0-5.0. 83.
(100) .. 2009 US2009104337A1. 04. CN101420862A. KR20090013172A 60/40-90/10. 2008 JP2008022842A. 2009. 02. NIPPON. 7. TW200930305. α-. 35-45. 20. 50 5-18. 0.5. 20 60-121. 20 0.1% 84. 2.
(101) pH 5.9-6.3. Table 32.. Important patent of enzyme extract. JP5316952A JP1993-316952. 1993/12/3 Production of fine green tea powder- mixed food 1993/12/3 Production of fine green tea powder-mixed food Manufacturing method of dietary supplement using extract of KR20040097872A 2004/11/18 green tea containing selenium, thereby preventing and treating diseases associated with selenium deficiency CN1923021A 2007/3/7 Preparation process of green tea extract WO2007122818A1 2007/11/1 Process for producing purified green tea extract WO2007122817A1 2007/11/1 Process for producing purified green tea extract Method for preparing theaflavin and thearubigin from fresh CN101096693A 2008/1/2 green tea JP2008022842A 2008/2/7 Green tea leaf pickle and method for producing the same JP2008-022842. 2008/2/7. Green tea leaf pickle and method for producing the same. CN101223927A. 2008/7/23 Fresh green tea solid drink and producing process thereof Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of US2008194675A1 2008/8/14 prostate cancer and for the treatment of prostate hypertrophy (BHP) CN101263853A 2008/9/17 Gingko green tea fermentation health care beverage KR20090008230A 2009/1/21 Process for producing purified green tea extract KR20090013172A 2009/2/4. Process for producing purified green tea extract. US2009104337A1 2009/4/23 Process for producing purified green tea extract CN101420862A CN101455255A CN101455252A CN101455251A CN101455250A TW200930305. 2009/4/29 2009/6/17 2009/6/17 2009/6/17 2009/6/17 2009/7/16. Process for producing purified green tea extract Preparation method of beverage containing green tea Preparation method of green tea beverage Preparation method of green tea beverage Preparation method of beverage containing green tea. 85.
(102) : 1.. 36.7% 1986. 11. pH. CN85103794A. 7.5-8.5 1987 CN85105228A. 90%-95% 1993. 7. 2009. 153. IPC. 86. 1.
(103) 2.. 36.7% 1980 2005. 2007. 1993. 33. 39 1980. 1980-099157. 27.2%. FROZEN TEA. 7 HORINO KENJI. 2010 WO2010131591A1. Funakawa Emiko. 30g 60-100. 11. 150-300g (1-10%). 5. 600-750g pH. (pH=6.5). IPC. 87. (60-100. ). 10.
(104) 3.. 13%. IPC (A61K008). 4.. 9.7% IPC. 2001 (A61K036). 5.. 88.
(105) 54 4 7. 100% 32% 2007. 6. 200900010. 2007. (. 2007) 5 Table 33. A list of the top five companies in taiwan. (. ) (. ) (. ) (. ) (. ). 19. 0. 0. 39. 1. 4. 7. 100%. 4. 0. 0. 16. 1. 2. 2. 32%. 3. 0. 0. 4. 1. 16. 2. 17%. 1. 0. 0. 8. 1. 2. 1. 12%. 1. 0. 0. 8. 1. 2. 1. 12%. 161. 0. 89.
(106) 20 3D 7. 5. :. Table 34. A list of through health food products by Uni-President Enterprises Co., Ltd.. 1 2 3 4 5. A00006 0 A0052 A00056 A00060 A00065. 6. A00067. 7 8 9 10 11 12 13 14 15 16. A00073 A00085 A00090 A00105 A00109 A00111 A00118 A00120 A00129 A00136. 17. A00159. 18 19 20. A00160 A00176 A00181. AB. TGL. 3D LP33. AB. 90. ,.
(107) Table 35. The patent through health food by Uni-President Enterprises Co., Ltd.. 1 2 3 4. / 200409597 200425837 200510523 200513191. / 2004/6/16 2004/12/1 2005/3/16 2005/4/16. 5 6. I238852 I242439. 2005/9/1 2005/11/1. 7 8 9 10 11 12 13 14 15. 200604345 I252736 I256882 200630043 200701892 I277413 200712201 200719837 200726476. 2006/2/1 2006/4/11 2006/6/21 2006/9/1 2007/1/16 2007/4/1 2007/4/1 2007/6/1 2007/7/16. AGLYCON. 16 17 18 19 20 21 22 23 24 25 26 27 28. I290176 200806187 200808959 I293553 200819054 I302442 I316545 200948277 201004569 201029659 I334336 201043143 201100088. 2007/11/21 2008/2/1 2008/2/16 2008/2/21 2008/5/1 2008/11/1 2009/11/1 2009/12/1 2010/2/1 2010/8/16 2010/12/11 2010/12/16 2011/1/1. AGLYCON. 91.
(108) KVASENKOV OLEG IVANOVICH. KAO CORP. KVASENKOV OLEG IVANOVICH 2005 RU2003123448A. 1. METHOD FOR OBTAINING JELLY. MARMALADE. 2010. 8. RU2397666C1. PRODUCTION. METHOD OF FLAVOURED COFFEE DRINK "ODINTSOVSKIY". 2:2:1. 92.
(109) KAO CORP (IPC: A23F003) 1986 JP61280414A. 12. HAIR COSMETIC. 2009. 4. CN101420862A. Process for. producing purified green tea extract (. 60/40-90/10). NEW CHAPTER INC NEWMARK THOMAS SCHULICK PAUL 2010. 27 6. 7. 4. 93. 2001.
(110) Table 36.. NEW CHAPTER INC Important patent in NEW CHAPTER INC. / / US2009110757A1 2009/04/30 Methods for modulating eicosanoid metabolism US2008233218A1 2008/09/25 Methods for treating oral cancers with herbal compositions NZ548277A 2009/07/31 Methods for treating prostatic intraepithelial neoplasia with herbal compositions WO2007041276A2 2007/04/12 Methods for modulating apoptosis, cellgrowth, and protein expression with herbal compositions US6261607B1 2001/07/17 Composition for promoting prostate health containing selenium and herbal extracts US6264995B1 2001/07/24 Herbal composition for reducing inflammation and methods of using same US2006078631A1 2006/04/13 Methods for treating glioblastoma with herbal compositions WO02080682A1 2002/10/17 Improved anti- inflammatory herbal composition and method of use JP2010047593A 2010/03/04 Composition and method for smoke detoxification US2010074977A1 2010/03/25 Methods for treating glioblastoma with herbal compositions NZ548276A 2010/01/29 Methods for treating prostate cancer with herbal compositions US2006240130A1 2006/10/26 Methods for treating prostate cancer with herbal compositions WO2005056033A1 2005/06/23 Methods for treating prostatic intraepithelial neoplasia with herbal compositions WO2005056032A1 2005/06/23 Methods for treating prostate cancer with herbal compositions KR20070000426A 2007/01/02 Methods for treating prostatic intraepithelial neoplasia with herbal compositions KR20070000425A 2007/01/02 Methods for treating prostate cancer with herbal compositions KR20090039829A 2009/04/22 Improved anti- inflammatory herbal composition and method of use 2010-047593 2010/03/04 Composition and method for smoke detoxification 07622142 2009/11/24 Methods for treating glioblastoma with herbal compositions 07744934 2010/06/29 Methods for modulating eicosanoid metabolism 07744931 2010/06/29 Methods for treating oral cancers with herbal compositions. AMOREPACIFIC CORP. IOPE (. ). 2008. 8. 94.
(111) 50% ITO EN LTD. 1966 4. 1989. 2009. 8. TAIYO KAGAKU CO LTD 1948. ISO-9001 334. 1989. 8. SunPhenon. 5. 1998. 1991. 1 1994. 11 2010. SunPhenon. 4 FTE. 2. A00179 1991. 2. Pseudomonas citronellosis GEA. 1996. 5. pH 9 – 12. 95.
(112) 10. 2010 04. TW201014838 3 α-. α-. 2006 5. Yun /. EGCG. 4. EGCG (Yun et al 2006) KR20090027180A EGCG. 2010. 2009. 03. 07. US2010178365A1. ECG EGCG. 96. ECG.
(113) Table 37.. Important patent in blood sugar. CN1071844 KR20020026920A CN1403017A CN1543879. 1993/5/12 2002/4/12 2003/3/19 2004/11/10. KR20090027180A 2009/3/16 TW201014838. 2010/4/16. CN101715854A. 2010/6/2. CN101755953A. 2010/6/30. US2010178365A1 2010/7/15 CN101861898A 2010/10/20. Method of producing grain wine using green tea extract Selenium-rich konjaku- green tea health food Manufacturing methods of green tea drink or green tea powder by using the techniques eliminating galated catechin and parathion from green tea extracts α Green tea extract with blood sugar reducing effect and preparation method thereof Epicatechin deficient green tea. 97.
(114) . 1976. ~2010. (Patent Guider 2008) PatentTech : 1.. 2.. 3.. 98.
(115) . 36,000. 68.7. 99.
(116) Adhami VM, Mukhtar H (2006). Polyphenols from green tea and pomegranate for prevention of prostate cancer. Free Radic Res 40: 1095-1104. Ahmad N, Cheng P, Mukhtar H (2000). Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun 275: 328-334. Bae JY, Choi JS, Choi YJ, Shin SY, Kang SW, Han SJ et al (2008). (-)Epigallocatechin gallate hampers collagen destruction and collagenase activation in ultraviolet-B-irradiated human dermal fibroblasts: involvement of mitogen-activated protein kinase. Food Chem Toxicol 46: 1298-1307. Bigelow RL, Cardelli JA (2006). The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene 25: 1922-1930. Birketvedt GS, Travis A, Langbakk B, Florholmen JR (2002). Dietary supplementation with bean extract improves lipid profile in overweight and obese subjects. Nutrition 18: 729-733. Brand MD, Buckingham JA, Esteves TC, Green K, Lambert AJ, Miwa S et al (2004). Mitochondrial superoxide and aging: uncoupling-protein activity and superoxide production. Biochem Soc Symp: 203-213. Butt MS, Sultan MT (2009). Green tea: nature's defense against malignancies. Crit Rev Food Sci Nutr 49: 463-473. Cao J, Mathews MK, McLeod DS, Merges C, Hjelmeland LM, Lutty GA (1999). Angiogenic factors in human proliferative sickle cell retinopathy. Br J Ophthalmol 83: 838-846. Cho SY, Park PJ, Shin HJ, Kim YK, Shin DW, Shin ES et al (2007). (-)-Catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3-L1 cells. Am J Physiol Endocrinol Metab 292: E1166-1172. Crespy V, Williamson G (2004). A review of the health effects of green tea catechins in in vivo animal models. J Nutr 134: 3431S-3440S. Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD (2004). Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India 52: 794-804.. 100.
(117) Dong Z, Ma W, Huang C, Yang CS (1997). Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res 57: 4414-4419. Ernst H (1998). Patent portfolios for strategic R&D planning. . Journal of Engineering and Technonlgy Management 30: 279-308. Heck DE, Kagan VE, Shvedova AA, Laskin JD (2005). An epigrammatic (abridged) recounting of the myriad tales of astonishing deeds and dire consequences pertaining to nitric oxide and reactive oxygen species in mitochondria with an ancillary missive concerning the origins of apoptosis. Toxicology 208: 259-271. Kumar N, Shibata D, Helm J, Coppola D, Malafa M (2007). Green tea polyphenols in the prevention of colon cancer. Front Biosci 12: 2309-2315. Liang W, Lee AH, Binns CW, Huang R, Hu D, Zhou Q (2009). Tea consumption and ischemic stroke risk: a case-control study in southern China. Stroke 40: 2480-2485. Maeda-Yamamoto M, Kawahara H, Tahara N, Tsuji K, Hara Y, Isemura M (1999). Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells. J Agric Food Chem 47: 2350-2354. Meeran SM, Akhtar S, Katiyar SK (2009). Inhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation. J Invest Dermatol 129: 1258-1270. Miura Y, Chiba T, Tomita I, Koizumi H, Miura S, Umegaki K et al (2001). Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr 131: 27-32. Mu LN, Zhou XF, Ding BG, Wang RH, Zhang ZF, Jiang QW et al (2003). [Study on the protective effect of green tea on gastric, liver and esophageal cancers]. Zhonghua Yu Fang Yi Xue Za Zhi 37: 171-173. Nakagawa T, Yokozawa T (2002). Direct scavenging of nitric oxide and superoxide by green tea. Food Chem Toxicol 40: 1745-1750. Raederstorff DG, Schlachter MF, Elste V, Weber P (2003). Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 14: 326-332. Sartippour MR, Heber D, Ma J, Lu Q, Go VL, Nguyen M (2001). Green tea and its catechins inhibit breast cancer xenografts. Nutr Cancer 40: 149-156. Sazuka M, Murakami S, Isemura M, Satoh K, Nukiwa T (1995). Inhibitory effects of green tea infusion on in vitro invasion and in vivo metastasis of mouse lung carcinoma cells. Cancer Lett 98: 27-31.. 101.
(118) Shimizu M, Deguchi A, Hara Y, Moriwaki H, Weinstein IB (2005). EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochem Biophys Res Commun 334: 947-953. Shimotoyodome A, Haramizu S, Inaba M, Murase T, Tokimitsu I (2005). Exercise and green tea extract stimulate fat oxidation and prevent obesity in mice. Med Sci Sports Exerc 37: 1884-1892. Song XZ, Xia JP, Bi ZG (2004). Effects of (-)-epigallocatechin-3-gallate on expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in fibroblasts irradiated with ultraviolet A. Chin Med J (Engl) 117: 1838-1841. Suganuma M, Kurusu M, Suzuki K, Tasaki E, Fujiki H (2006). Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene. Int J Cancer 119: 33-40. Suzuki E, Yorifuji T, Takao S, Komatsu H, Sugiyama M, Ohta T et al (2009). Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort. Ann Epidemiol 19: 732-739. Syu KY, Lin CL, Huang HC, Lin JK (2008). Determination of theanine, GABA, and other amino acids in green, oolong, black, and Pu-erh teas with dabsylation and high-performance liquid chromatography. J Agric Food Chem 56: 7637-7643. Thangapazham RL, Passi N, Maheshwari RK (2007). Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biol Ther 6: 1938-1943. Tijburg LB, Wiseman SA, Meijer GW, Weststrate JA (1997). Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis 135: 37-47. Toi M, Kashitani J, Tominaga T (1993). Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 55: 371-374. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH et al (1992). Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887. Yokozawa T, Nakagawa T, Kitani K (2002). Antioxidative activity of green tea polyphenol in cholesterol-fed rats. J Agric Food Chem 50: 3549-3552. Yun SY, Kim SP, Song DK (2006). Effects of (-)-epigallocatechin-3-gallate on pancreatic beta-cell damage in streptozotocin-induced diabetic rats. Eur J Pharmacol 541: 115-121. Yusuf N, Irby C, Katiyar SK, Elmets CA (2007). Photoprotective effects of green tea polyphenols. Photodermatol Photoimmunol Photomed 23: 48-56. 102.
(119) Zhang M, Holman CD, Huang JP, Xie X (2007). Green tea and the prevention of breast cancer: a case-control study in Southeast China. Carcinogenesis 28: 1074-1078.. 2008. 2008/02/04. 2007 1979. 13(1):10-18. 2010. 2011. 900. 2000 2009 2015. 2009. 2006. 4:88-90. 2009. 2009/10/16. 2002. 1995 2003. 2005 235:86-89 2009. 2009/10/27. 103.
(120) 2009 2009/10/14 1999. 31(9):1-15 酚. 2005. 2009. P09-13. 2009 2009/03/09. 2009. 2005. 2005. :. 2007. 2003 P23-36 2007. P01-07. 2005. 2009. 281:98-99 2010. 2010/12/17. 104.
(121) Abe, T., Ueoka, H. Maruyama, E. (2007) Method for producing refined green tea extract. JP2007135579A. JP2007-135579. Abe, T., Ueoka, H. Shibata, K. (2007) Method for producing refined green tea extract. JP2007-282569. JP2007-282568. Abe, T., Ueoka, H. Shibata, K. (2007) Process for producing purified green tea extract. WO2007122818A1. WO2007122817A1. Abe, T., Ueoka, H. Shibata, K. (2008) Process for producing purified green tea extract. EP2008525A1. EP2008524A1. Abe, T., Ueoka, H. Shibata, K. (2009) Process for producing purified green tea extract. KR20090008230A. KR20090013172A.US2009104337A1. Ahn, S. W. (2005) Production of green tea pills effective for eliminating constipation, maintaining skin resiliency and strengthening bones containing green tea and herbal plants. KR20050019476A. Alberte, R. S., Gow, R. T., Sypert, G, W. green tea species. US2008113044A1.. Li, D. (2008) Extracts and methods comprising. Amorepacific, (2008) Perfum composition for expressing the fragrance of green tea flower. CN101304725A. Arima, T., Kawamoto, A. & Oosawa H. (1985) Preparation of instant green tea. JP60009449A. JP1985-009449. Ariyoshi, M. (1999) Green tea paste. JP1999-266785. Baek, J. H., Han, S. H., Kim, J. H., So, S. & Yoo, B. H. (2002) Composition for external application on the skin, containing green tea leaf water. KR20020040099A. Baek, J. H., Jung, J. O. & So, S. (2002) Method for producing green tea powders. KR20020093504A. Baek, S. O., Na, H. H., Han, S. B., Bok, J.Y. & Yang, K. K. (1996) Manufacturing method of green tea. KR960010608B1 Bahaerguli, H. (2009) Preparation method of health- care green tea. CN101416665A. CN101416665. 105.
(122) Baiman, S. (2010) Method for processing green tea by microwaves. CN101653175A. Baiwu, L., Yiping, P. Xia, H. (2009) Preparation method of beverage containing green tea. CN101455255A. CN101455250A. Baiwu, L., Yiping, P. Xia, H. (2009) Preparation method of green tea beverage. CN101455252A. CN101455251A. Bang, G. P., Cho, G. S., Choi, H. G. & Kim, S. C. (2001) Preparation method of antiobesity green tea. KR20010081369A. Bang, G. P., Cho, G. S., Choi, H. G. & Kim, S. C. (2002) Slimming green tea product and manufacturing method thereof. KR20020033452A. Bang, G. S. (2003) Production for toothpaste by green tea extract. KR20030000275A. Baoguo F., Haiyang K., Shengrong S. & Guoxia T. (2010)Composition of plant extracts and application in preventing or treating scars.CN101837071A Bettuzzi, S., Corti, A. Corvetta, S. (2008) Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (BPH). US2008194675A1. Birketvedt, G. S. (2007) Northern white kidney bean extract and red kidney bean extract in combination with green tea extract in the treatment of obesity. WO2007035367A1. Birketvedt, G. S. (2009) Composition for treating obesity comprising extract from white kidney beans, red kidney beans, and green tea leaves. US07579027. Buckman, K. (2007) Brown seaweed extracts in capsules consisting of broad- spectrum freeze dried antioxidant concentrates, fucoidan, crystalloidals, mangosteen, hyaluronic acid, alpha lipoic acid, green tea extract, vitamin c, and black pepper extract with delivery systems for utilization of nutrients. US2007224215A1. Buxiang, S., Lingzhi, T., Baifeng, W., Zhihui, W. Zhenpeng, C. (2008) Method for preparing theaflavin and thearubigin from fresh green tea. CN101096693A. Cha, H. S., Han, D. S., Jang, D. J., Kim, S. H., Lee, Y. C., Na, K. J. Oh, S. W. (2005) Preparation of food composition having effects of preventing alcoholic fatty liver and reducing hangover by using green tea powder as main ingredient and herbs. KR20050023186A. Chae, Y. K. (2005) Beauty pack comprising yellow soil and green tea which removes waste matter from skin, inhibits skin aging, and enhances pimples and atopic dermatitis without stimulating skin and method for preparing same. KR20050024742A.. 106.
(123) Changbing, Y., Jian, J., Shengying, X. Qinghua, X. (2008) Concave-convex bar green tea liquid toothpaste and preparation thereof. CN101249055A. Changbing, Y., Jian, J., Shengying, X. Qinghua, X. (2008) Concave-convex bar jasmine flower green tea toothpaste and preparation (method) thereof. CN101249054A. Changbing, Y., Jian, J., Shengying, X. Qinghua, X. (2008) Concave-convex bar mother chrysanthemum green tea toothpaste and preparation (method) thereof. CN101249053A. Chaolong, L. (2010) Method for preparing honey green tea tablet. CN101632403A. Cheng, S., Mu, X. & Wang, D. (1999) Composition of radix sophorae flavescentis and green tea and its application in treating condyloma. CN1239669A. Chigarina, K., Alaverdiev, I. M. O., Zalevskaja, S., Taran, T. Romanycheva, O. (2004) "paradontol" tooth paste with green tea extract, fluorine and vitamins A and E. RU2241437C1. Chiwu, C. Fancun, K. (2010) Preparation and production process of sugar- free degreasing health- care green tea. CN101715854A. Cho, N. H., Kim, W. G., Lee, S. J., Park, H. U. & Sim, Y. C. (2003) Method of isolating high purity epigallocatechin gallate from green tea extract. KR20030046122A. Cho, Y. S., Kim, S. M. & Sung, S. G. (2002) Chicken meat product using green tea and production thereof. KR20020042794A. Choi, D. Y. & Han, G. H. (2004) Manufacturing method of dietary supplement using extract of green tea containing selenium, thereby preventing and treating diseases associated with selenium deficiency. KR20040097872A. Choi, J. S. (2002) Method of producing grain wine using green tea extract. KR20020026920A. Choi, J. S. (2002) Production of astringent using green tea and houttuynia cordata thunb. KR20020067029A Choi, J. Y., Jeon, B. B. Seo, H. J. (2006) Perfum composition for expressing the fragrance of green tea flower. KR100645879B1. Choi, J. Y., Jeon, B. B. Seo, H. J. (2007) Perfum composition for expressing the fragrance of green tea flower. WO2007055493A1. Choi, J. Y., Jeon, B. B. Seo, H. J. (2009) Perfum composition for expressing the fragrance of green tea flower. US2009306229A1.. 107.
(124) Choi, K. D., Chung, J. H., In, C. S., Kim, H. G., Kim, I. S., Kim, J. U., Kim, S. A., Lee, H. J., Lee, H. S., Leem, K. H., Park, H. J., Seo, J. C. & Yoo, Y. M. (2003) Acetylcholinesterase inhibitor comprising extract of green tea and pharmaceutical preparation, food product and feed product containing the same. KR20030044845A. Cuizhen, C. (2010) Green tea extract with blood sugar reducing effect and preparation method thereof. CN101755953A. Dan, L. (2009)Extracts and methods comprising green tea species. CN101454015A. Doering, T., Schreiner, V., Siefken, W., Sauermann, G., Rode, T. & Carstensen, S. (2003) Cosmetic and dermatological preparations containing catechins or green tea extracts for the treatment and active prevention of dry skin and other negative changes in the physiological homeostasis of healthy skin. WO03009825A2. Eguchi, K. (1987) Removal of green tea harsh ness and core water in production of oven roasted green tea. JP1987-201542. JP62201542A. Ekanayake, A., Bunger, J. R. & Mohlenkamp, J. M. J. (1999) Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color. US05879733. US5879733A. Ekanayake, A., Bunger, J. R., Mohlenkamp, J. & Marvin, J. (2001) Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color. US06268009. Ekanayake, A., Bunger, J. R., Mohlenkamp, J.& Marvin, J. (2000) Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color. US06063428. Feng, X., Xu, D. & Liu, Z. (2003) Green tea polyphenol anti- caries coating film. CN1401376A. Firion, J. (1997) Powders containing plant extracts e.g. fucus, green tea, and elder. FR2746648A1. Fukuchi, J. (1994) Soluble powder of microbial post- fermented tea from green tea. JP6046764A. JP1994-046764. Funakawa E., Ando T., Yoshida K. ＆ Shimura S. (2010) Method for producing polyaminecontaining food or drink. WO2010131591A1 Fusheng, Y. (2008) Method for preparing low caffeinum green tea. CN101189991A. Ge, Y., Yao, Z. & Ge, Y. (1998) Health green tea and producing method thereof. CN1187306A. CN1187306.. 108.
(125) Gonda, A. & Nakano, F. (1991) Carrying conveyor for green tea raw leaf. JP3195418A. JP1991-195418. Gow, R. T., Sypert, G. W. Li, D., Alberte, R. S. (2009) Extracts and methods comprising green tea species. KR20090010172A Gow, R. T., Sypert, G. W., Li, D. Alberte, R. S. (2007) Extracts and methods comprising green tea species. WO2007109802A2. Gow, R. T., Sypert, G. W., Li, D. Alberte, R. S. (2008) Extracts and methods comprising green tea species. MX2008012065A. Guangcai, H. (2009) Safflower green tea low sugar beverage. CN101375697A. Guoqin, B. (2009) Honeysuckle green tea. CN101485371A. Haixia, C., Xin, Z., Lingling, F. Peng, D. (2009) Method for extracting tea polysaccharides and tea polyphenol from coarse old green tea. CN101519458A. Han, C. S., Kim, J. G., Kim, K. H., Lee, Y. H., Park, S. M. Park, S. C. (2005) Anti-inflammatory/abirritant composition for cleaning anus, which is extracted from mixture of mugwort, purslane and green tea plant by using ethanol, methanol, propanol, butanol, glycerine, propyleneglycol, butylene glycol or mixture thereof as extraction solvent. KR20050001737A. Hao, Y., Shiyu, Y., Weichao, Y. extract. CN101703130A.. Weiqiang, Y. (2010) Technology for producing green tea. Hara, M. & Okushio, K. (1992) Manufacture of green tea polyphenol. JP4020589A. JP1992-020589. Haruta, C., Sano, T. & Nagasawa, S. (1981) Boiled rice with green tea poured on it to be prepared instantly. JP1981-029970. JP56029970A. Hashimoto, H., Hara, K., Kuwabara, N. & Yashiki, I. (1987) Ground green tea having improved preservability and production thereof. JP1987-019051. JP62019051A Hashizume, K., Iwasaki, M. JP2005-160348.. Takatani, H. (2005) Method for producing green tea extract.. Honda, K., Imazawa, T., Kubota, Y. & Nakatsubo, T. (2004) Extracting and/or squeezing method for tea such as green tea, black tea, and oolong tea. JP2004-041237. Hong, W. (2007) Supercritical extracting of fern flavone and preparation process of perflavone green tea. CN100999511A. CN100999511. 109.
(126) Hongchang, Z. (1993) Process for extracting natural biological activator from green tea. CN1071844A. CN1071844. Hongyu, Z. (2010) Green tea beverage for reinforcing immunity, reducing blood fat, losing weight and clearing away summer heat. CN101658221A. Hu, Q. Y. (2005) Green tea fresh- retaining nano packaging material and its use. CN1709979A. Ikeda, M. (1999) Apparatus for treating waste heat and dust of leaf beating machine for green tea manufacturing or rough rolling machine for green tea manufacturing. JP11028058A. JP1999-028058. Imaeda, T., Ushitani, K., Takihara, T. production method. JP2009-201384.. Nishitani, E. (2009) Green tea extract, its use and. Imaeda, T., Ushitani, M., Takihara, T. Nishitani, E. (2009) Green tea extract and use and manufacturing method of same. WO2009107179A1. Inamoto, M., Aono, A. & Suzuki, J. (1995) Production of green tea paste. JP7067532A. JP1995-067532. Ishikawa, T. (1996) Green tea without deteriorating ingredient, its production and method for packaging. JP1996-131077 Ishizuka, Y. (1990) Green tea manufacturing and extracting machine. JP2308758A. JP1990-308758. Iwasaki, M., Satake, N., Yamamoto, S., Hosoya, N. producing purified green tea extract. JP2007-061037.. Hoshino, E. (2007) Method for. Jeon, C. S. & Yu, S. C. (2004) Method for manufacturing green tea juice to prepare steamed green tea- rice. KR20040022912A. Jian, J., Changbing, Y., Shengying, X., Qinghua, X. (2008) Concave-convex bar green tea toothpaste and preparation thereof. CN101249051A. Jian, J., Changbing,Y., Qinghua, X. Shengying, X. (2008) Concave-convex bar fluorinecontaining green tea toothpaste and preparation (method) thereof. CN101249052A. Jian, J., Changbing,Y., Qinghua, X. Shengying, X. (2008) Concave-convex stick honeysuckle flower green tea toothpaste and preparing method. CN101244024A. Jiangke, W. (2008) Selenium-rich green tea and its producing method. CN101099431A.. 110.
(127) Jianxin, G., Jiaqiang, L., Bingwen, L., Shuyong, M., Yongqiang, S. Xinwen, X. (2010) Cistanche green tea and preparation method thereof. CN101700090A. Jianyong, C. (2009) Mushroom green tea beverage and preparation method. CN101548704A. Jie, Z., Jin, W., Shuhua, Z., Zhangbao, C. Jigang, G. (2009) Method for extracting highpurity epigallocatechin- 3-gallate from green tea. CN101381359A. Jin, L., Qipeng, L., Yang, S., Renguan, P., Huijun, L., Min, L. Xingdan, C. (2009) Apparatus and method for rapidly and nondestructively detecting content of green tea composition. CN101424636A. Jin, L., Qipeng, L., Yang, S., Renguan, P., Huijun, L., Min, L. Xingdan, C. (2009) Device for testing the ingredient content of green tea in quick and nondestructive manner. CN201307093Y. JiyuaN, Z. (2010) Supercritical extraction method of green tea extract. CN101637545A. Jufang, L. Zhuoma, D. (2009) Highland barley green tea and preparation thereof. CN101548703A. Jufang, L. Dojedrolma, (2010) Highland barley green tea and preparation method thereof. CN101642172A. Jun, S. S., Jung, Y. C., Kang, S. G., Kim. E. J. & Seo, J. G. (2004) Production of chestnut beverage having anticancer and antioxidant activity by mixing extract of chestnut inner skin which has hitherto been discarded, green tea leaf extract and polygonatum odoratum extract. KR20040102780A. Junfeng, Y., Yongquan, X., Haibo, Y., Jianxin, C. Fang, W. (2008) Fresh green tea solid drink and producing process thereof. CN101223927A. Jung, I. S. (2004) Noodle composition effective in preventing adult disease and reducing body weight, containing wheat flour, rice flour, black rice, black bean, black sesame, red grape, green tea, herba houttuyniae, fructus aurantii immaturus and folium mori. KR20040036701A. Jung, I. S. (2004)Fat foods containing green tea, tangerine peel, calcium from waste shells, chitosan and boiled beans having function of inhibiting lipid absorption and production thereof. KR20040052991A. Jung, M. J. (2004) Manufacturing method of health seasoning salt including green tea and chitooligosaccharide and health seasoning salt manufactured thereby.KR20040001369A. Jung, S. T., Kang, J. H., Noh, G. H. & Park, Y. G. (2001) Method for extracting and purifying anticancer component from green tea. KR100307437B1. 111.
Outline
相關文件
because Nakagami parameter has physical meanings associated with envelope distribution and scatterer properties. We used blue for pre-Rayleigh, white for Rayleigh, and red
日光照射法 紫外線照射法 煮沸消毒法 蒸汽消毒法 巴氏消毒法 冷卻冷凍法
In weather maps of atmospheric pressure at a given time as a function of longitude and latitude, the level curves are called isobars and join locations with the same pressure.
包括具有藥理活性的高分子和低分子藥物高分子化或
Center for Faculty Development, Department of medical education, Taichung Veterans General hospital 1 School of Medicine, National Yang-Ming University, Taipei, Taiwan 2.
臺大機構典藏NTUR (National Taiwan University 二 Repository, http://ntur.lib.ntu.edu.tw) 經驗與協助推 動臺灣學術機構典藏TAIR (Taiwan Academic Institutional Repository,
172, Zhongzheng Rd., Luzhou Dist., New Taipei City (5F International Conference Room, Teaching Building, National Open University)... 172, Zhongzheng Rd., Luzhou Dist., New
On the other hand Chandra and Taniguchi (2001) constructed the optimal estimating function esti- mator (G estimator) for ARCH model based on Godambes optimal estimating function
